Pharmaceutical Reimbursement Board; suspension of maximum allowable cost limits on specific drug products--HCFA.
The Pharmaceutical Reimbursement Board announces the suspension of the Maximum allowable cost (MAC) limit on penicillin G potassium, oral tablets, 800 mu, effective August 18, 1963. The limit for this drug product was published on December 11, 1978 (43 FR 57972) and became effective on October 15, 1979. The suspension of the MAC limit on penicillin G potassium, oral tablets, 800 mu, results from the unavailability of this product in the marketplace at or below the MAC limit. The Pharmaceutical Reimbursement Board may establish a new MAC limit on this drug product in the future.